Medscape Conference Coverage, based on selected sessions at the:
American Urological Association (AUA) 2007 Annual Meeting
May 19 - 24, 2007, Anaheim, California
This activity is not sanctioned by, nor a part of, the American Urological Association.
Topic OverviewsAUA GuidelinesConference News- No Disadvantage Seen With Intermittent Androgen Suppression for Advanced Prostate CancerIntermittent androgen suppression therapy does not diminish survival nor hasten tumor progression compared with continuous therapy, and it may confer a small advantage in quality of life.
Medscape Medical News, May 25, 2007 - Erectile Dysfunction Drugs Show Promise in Treatment of Lower Urinary Tract SymptomsIn 3 studies, men receiving vardenafil, sildenafil, or tadalafil had improved symptoms compared with those receiving placebo.
Medscape Medical News, May 25, 2007 - FDA Requests More Data for Prostate Cancer VaccineInvestigator expresses disappointment over the FDA's decision regarding Provenge.
Medscape Medical News, May 23, 2007 - CME/CE AUA Updates Prostate Cancer Treatment GuidelinesThe American Urological Association has issued updated guidelines for diagnosing and treating clinically localized prostate cancer, emphasizing honest clinician-patient communication.
Medscape Medical News, May 22, 2007 - International Panel Updates Ureteral Stone GuidelinesNew guidelines for the management of ureteral stones add laparoscopy and medical expulsive therapy to the list of treatment options.
Medscape Medical News, May 22, 2007 - Single Mid-Life PSA Measurement Predicts Prostate Cancer RiskA single prostate-specific antigen measurement obtained when a man is in his 40s strongly predicts his risk for advanced-stage prostate cancer later in life.
Medscape Medical News, May 21, 2007
|
Legal Disclaimer
The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American Urological Association. These materials and the related activity are not sanctioned by the American Urological Association or the commercial supporter of the conference and do not constitute an official part of that conference.
Copyright © 2007 Medscape.
